Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2010
03/25/2010WO2010031266A1 The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridyl methyl)amino-3-pyridinecarboxamide
03/25/2010WO2009153496A3 Ppar agonist compounds and preparation and uses thereof for treating diabetes and/or dyslipidemia
03/25/2010WO2009146539A8 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
03/25/2010US20100076199 Process for the preparation of substituted pyridone carboxylic acids
03/25/2010US20100076015 Aminopyridine Derivatives
03/25/2010US20100075971 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075942 N-phenyl-4-pyridin-2-yl-benzamide derivatives as histone deacylase (hdac) inhibitors for the treatment of cancer
03/25/2010US20100074898 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors
03/25/2010CA2737738A1 Heterocyclic carboxamide compounds
03/25/2010CA2737524A1 Organic compounds for applications in bacterial infections treatment
03/25/2010CA2737038A1 Amide compounds, compositions and uses thereof
03/25/2010CA2736971A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
03/25/2010CA2736664A1 The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide
03/24/2010EP2166002A1 Chiral organic catalysts for the enantioselective reduction of n-alkyl and n-benzyl-substituted alicyclic and cyclic imines
03/24/2010EP2166000A1 7-, 8- and 9-substituted tetracycline compounds
03/24/2010EP2165709A2 Lysine based compounds
03/24/2010EP2164825A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010EP2164480A1 Mutual prodrugs and methods to treat cancer
03/24/2010EP1710236B1 Derivatives of pyridine and quinoline
03/24/2010EP1409460B1 Novel synthesis of heteroarylamine intermediate compounds
03/24/2010CN101679761A Pyridinone based azo dyes and their metal complex salts
03/24/2010CN101679353A A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
03/24/2010CN101679304A Pyridazine-, pyridine- and pyrane-derivatives as GPBAR1 agonisis
03/24/2010CN101679267A Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
03/24/2010CN101679266A PIM kinase inhibitors and methods of their use
03/24/2010CN101679265A Salts of isophosphoramide mustard and analogs thereof
03/24/2010CN101679264A inhibitors of focal adhesion kinase
03/24/2010CN101679263A fluorinated derivatives of deferiprone
03/24/2010CN101679262A Pyridone compound
03/24/2010CN101679261A Piperazine and piperidine mglur5 potentiators
03/24/2010CN101679219A Synthetic ion channels
03/24/2010CN101679191A Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010CN101678330A Process for the production of palladium supported catalysts for catalyzing heck, suzuki-miyaura sonogashira coupling and buchwald-hartwig reactions
03/24/2010CN101678064A Methods of treating or preventing emesis using growth hormone secretagogues
03/24/2010CN101678007A gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/24/2010CN101677570A synergistic pesticidal mixtures
03/24/2010CN101677552A Aminoazoline and urea derivatives for combating animal pests
03/24/2010CN101676267A N-4-(1-cyan cyclopentyl) phenyl-2-(4-picolyl) amidogen-3-pyridinecarboxamide salt
03/24/2010CN101676266A Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
03/24/2010CN100595573C Method of measuring surface plasmon resonance and noble metal compound for use in the method
03/23/2010US7683179 crystal structure
03/23/2010US7683097 Topoisomerase inhibitors
03/23/2010US7683096 Acid amide derivatives, process for producing these, and pest control agent containing these
03/23/2010US7683063 inhibiting Vanilloid Receptor 1; Inflammatory bowel disease; Crohn's disease and ulcerative colitis; cyclo(hetero)alkenyl compound
03/23/2010CA2418652C Novel 3-substituted urea derivatives and medicinal use thereof
03/23/2010CA2354387C Substituted pyridine herbicides
03/18/2010WO2010030237A1 Ligands for transition metal catalysed olefin polymerization
03/18/2010WO2010028776A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/18/2010WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors
03/18/2010WO2009152168A3 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
03/18/2010US20100069642 Crystalline s-(-)-amlodipine adipic acid salt anhydrous and preparation method thereof
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069447 Benzamide derivatives and uses related thereto
03/18/2010US20100069446 L-threonine derivatives of high therapeutic index
03/18/2010US20100069445 Method for the separation of s-(-)-amlodipine from racemic amlodipine
03/18/2010US20100069444 Phenathrenone compounds, compositons and methods
03/18/2010US20100069443 Compound with benzamide skeleton having cyclooxygenase-1 (cox-1)-selective inhibitory activity
03/18/2010US20100069440 Pyridine non-classical cannabinoid compounds and related methods of use
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100068553 Ultra-thin hydrophobic and oleophobic layer, method of manufacture and use in watchmaking as an epilame
03/18/2010US20100068138 Structurally rigid dopamine d3 receptor selective ligands and process for making them
03/18/2010US20100065416 6-chloro-2-trichloromethyl pyridine preparation method
03/18/2010CA2736530A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2010EP2163542A2 Bi-functional compound positively charged at first pH and negatively charged at second pH, solid support comprising the bi-functional compound, and method of isolating nucleic acid using the same
03/17/2010EP2163541A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2010EP2161998A1 Novel methods
03/17/2010EP1817300B1 Potentiators of glutamate receptors
03/17/2010EP1546133B1 N-substituted-2-oxodihydropyridine derivatives as npy antagonists
03/17/2010EP1095035B1 Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used
03/17/2010CN101675040A Pyridine derivatives
03/17/2010CN101675035A Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
03/17/2010CN101675034A Pyridone derivatives as p38a mapk inhibitors
03/17/2010CN101675033A Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
03/17/2010CN101674727A Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
03/17/2010CN101673852A Electrolyte additive and electrolyte and lithium ion battery containing same
03/17/2010CN101671304A Ionic liquid containing cinnamyl functional groups and preparation method thereof
03/17/2010CN101671300A Method for preparing 2-cyano-3, 6-dichloropyridine
03/17/2010CN101671299A Method for synthesizing Nexavar
03/17/2010CN101671298A Synthesis method of 2-chloronicotinoyl chloride
03/17/2010CN101671297A Method for synthesizing 4-(3-iodo-2-pyridinyl) piperazine compound
03/17/2010CN101671296A New method for obtaining 2-chloro-3-methylpyridine from mixture of 2-chloro-5-methylpyridine and 2-chloro-3-methylpyridine
03/17/2010CN101671295A Preparation method of PYP
03/17/2010CN101671257A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/17/2010CN101671227A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/17/2010CN101671220A Method for preparing sulfamide as intermediate of sulfonylurea herbicide
03/17/2010CN101671217A Method for preparing organic chlorofluoro compounds from organic polychlorinated compounds
03/16/2010US7678920 [3-(6-Chloropyridin-3-yl)-2-methylpropyl](methyl)oxido- lambda 4-sulfanylidenecyanamide; aphidicides
03/16/2010US7678919 Method for producing pentacyclic taxans
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678819 Acetylene derivatives and their use for binding and imaging amyloid plaques
03/16/2010US7678818 5-chloro-N-(4-cyclopentyl-benzyl)-2-isopropylamino-N-[2-(3-trifluoromethyl-phenyl)-ethyl]-benzamide; cholesteryl ester transfer protein (CETP) inhibitors; Atherosclerosis; cardiovascular disorders
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678811 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
03/16/2010US7678792 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2500492C Aryl sulfonamides
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2372575C Bradykinin receptor antagonists